Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2009 by Ora Bio Ltd..
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Ora Bio Ltd.
ClinicalTrials.gov Identifier:
NCT00745511
First received: September 2, 2008
Last updated: June 7, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2010
  Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)